Technology | April 17, 2009

FDA Approves New Labeling for Somanetics’ INVOS Oximeter


April 17, 2009 - Somanetics Corp. has received FDA 510(k) approval to expand the labeling for its INVOS Cerebral/Somatic Oximeter.

The new labeling allows a claim of improved patient outcomes after surgery when the INVOS System is used to manage therapies in patients above 2.5 kilograms (kg) at risk for reduced or absent blood flow. Its indications for use now reflect the INVOS System's ability to generate accurate real-time measurements of blood oxygen saturation in this same patient population, in addition to its previous clearance as a trend monitor in any individual.

The INVOS (In Vivo Optical Spectroscopy) Cerebral/Somatic Oximeter noninvasively monitors site-specific blood oxygen levels to help surgical and critical care teams protect their patients against brain and vital organ area damage, or even death.

“We use the INVOS System routinely in all our cardiac surgeries in an effort to protect patients from ischemic brain complications. I suspect today's news will spark further adoption of the technology by the medical community,” said Marc S. Kanchuger, M.D., associate professor and chief of cardiothoracic surgery and transplant anesthesia at NYU Medical Center.

For more information: www.somanetics.com.


Additional Content

News | Cardiovascular Surgery

May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...

Home May 05, 2026
Home
News | Cardiovascular Surgery

March 24, 2026 — iPerf, a company specializing in the development of medical devices for cardiopulmonary support, has ...

Home March 25, 2026
Home
News | Cardiovascular Surgery

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Home February 13, 2026
Home
News | Cardiovascular Surgery

Feb. 11, 2026 – Columbia HeartSource, an extension of Columbia University Irving Medical Center’s Department of Surgery ...

Home February 12, 2026
Home
News | Cardiovascular Surgery

Feb. 6, 2026 — Robert Wood Johnson University Hospital (RWJUH), in partnership with Rutgers Robert Wood Johnson Medical ...

Home February 06, 2026
Home
Subscribe Now